
Xylem (XYL) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Xylem (XYL) last issued guidance on October 27, 2026 for Q4 2026. The company guided earnings per share in the range of $1.39 - $1.44, compared to a consensus EPS estimate of $1.63. Xylem also guided revenue in the range of $2.3B - $2.3B for the period.
Compared to prior guidance, Xylem lowered its revenue forecast from a prior range of $8.95B - $8.95B.
Xylem has issued 23 guidance updates between November 1, 2022 and October 27, 2026. During this period, the company raised its outlook 12 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.45 | $1.34 | $1.08 | $1.41 |
| Actual | $1.44 | $1.46 | $1.12 | $1.42 |
| Surprise | -0.69% | +8.96% | +3.70% | +0.71% |
| Revenue | ||||
| Estimate | $2.28B | $2.35B | $2.11B | $2.38B |
| Actual | $2.20B | $2.34B | $2.13B | $2.40B |
| Surprise | -3.38% | -0.39% | +0.73% | +0.90% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $1.53 | $1.20 | $1.58 | $1.64 |
| Revenue | ||||
| Consensus | $2.35B | $2.17B | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $1.44 | $1.45 | -0.69 % |
| Q2 | Jul 28, 2026 | $1.46 | $1.34 | 8.96 % |
| Q1 | Apr 28, 2026 | $1.12 | $1.08 | 3.70 % |
| Q4 | Feb 10, 2026 | $1.42 | $1.41 | 0.71 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $2.20B | $2.28B | -3.38 % |
| Q2 | Jul 28, 2026 | $2.34B | $2.35B | -0.39 % |
| Q1 | Apr 28, 2026 | $2.13B | $2.11B | 0.73 % |
| Q4 | Feb 10, 2026 | $2.40B | $2.38B | 0.90 % |